796 Ovarian Cancer Trials Are Recruiting Right Now
A data-driven look at the clinical trial landscape for ovarian cancer. Where the trials are, what they're testing, and how to find one near you.
Read article →
Clinical Trials Research & News
Clinical trial updates, drug approvals, and treatment advances. Data-led coverage of ovarian cancer research.
Clinical Trials 
Treatment Advances PARP Inhibitors Changed Ovarian Cancer Treatment
Olaparib, niraparib, rucaparib. How a new class of drugs extended progression-free survival to 40 months for some patients with BRCA mutations.
Read article →
Treatment Advances What Patients Should Know About Mirvetuximab Soravtansine
The first antibody-drug conjugate approved for ovarian cancer targets FRa-positive tumors. Here's how it works, who it's for, and what the trial data shows.
Read article →
Talc Litigation Philadelphia Jury Orders J&J to Pay $250K in Talc Verdict
Another jury finds Johnson & Johnson liable in a talc ovarian cancer case. The verdict adds to a growing body of trial outcomes across multiple jurisdictions.
Read article →
Research Ovarian Cancer Survival Rates: What the Data Shows in 2026
Five-year survival rates vary dramatically by stage at diagnosis. Stage I patients have a 93% survival rate. Stage IV drops to 31%. The gap is closing, slowly.
Read article →
Clinical Trials CAR-T Cell Therapy Enters Ovarian Cancer Trials
Chimeric antigen receptor T-cell therapy transformed blood cancer treatment. Now researchers are testing engineered T-cells against solid ovarian tumors in 18 active trials.
Read article →
Research ROSELLA Trial Meets Overall Survival Endpoint
The Phase 3 ROSELLA trial reported positive overall survival data for a combination therapy approach in platinum-resistant ovarian cancer. Here's what the numbers show.
Read article →
Patient Resources How to Find a Gynecologic Oncologist
Ovarian cancer treatment outcomes improve significantly when care is led by a gynecologic oncologist. Three steps to find the right specialist for your diagnosis.
Read article →
Clinical Trials HIPEC Surgery: What Ovarian Cancer Trials Show
Heated intraperitoneal chemotherapy delivered during surgery showed a 12-month overall survival benefit in the landmark OVHIPEC trial. New studies are testing the approach further.
Read article →
Treatment Advances ADC Drugs: The Next Frontier in Ovarian Cancer
Antibody-drug conjugates deliver chemotherapy directly to cancer cells. With 20 active trials in ovarian cancer, ADCs represent one of the fastest-growing treatment categories.
Read article →
Talc Litigation Talc Litigation in 2026: What to Know
Johnson & Johnson's third bankruptcy attempt to resolve talc claims. The current state of federal and state litigation, recent verdicts, and what comes next for claimants.
Read article →
Research Immunotherapy and Ovarian Cancer: Where Checkpoint Inhibitors Stand
Checkpoint inhibitors haven't matched their success in other cancers. But 64 active immunotherapy trials are testing new combinations and patient selection strategies.
Read article →Search Clinical Trials
796 active ovarian cancer trials across 65 countries. Filter by treatment type, phase, and location.
What We Cover
Clinical Trial Updates
New trials recruiting, results published, FDA actions. We track every ovarian cancer trial on ClinicalTrials.gov and surface the ones that matter.
Treatment Advances
Drug approvals, new combinations, surgical techniques. From PARP inhibitors to ADCs, the therapies changing ovarian cancer outcomes.
Published Research
Peer-reviewed studies, conference presentations, survival data. The evidence behind treatment decisions, explained in plain language.
Talc Litigation
Verdicts, settlements, and Johnson & Johnson updates. Tracking the legal landscape for ovarian cancer talc claims.
Patient Resources
How to find specialists, understand your diagnosis, navigate the healthcare system. Practical guides built for patients and caregivers.